Morse Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-7,488
| Closed | -$892K | – | 360 |
|
|
2024
Q3 | $892K | Sell |
7,488
-20,148
| -73% | -$2.4M | 0.19% | 96 |
|
|
2024
Q2 | $3.95M | Sell |
27,636
-1,059
| -4% | -$151K | 0.96% | 34 |
|
|
2024
Q1 | $3.68M | Buy |
28,695
+4,390
| +18% | +$564K | 0.94% | 40 |
|
|
2023
Q4 | $2.51M | Buy |
24,305
+4,295
| +21% | +$444K | 0.74% | 44 |
|
|
2023
Q3 | $1.82M | Buy |
20,010
+1,564
| +8% | +$142K | 0.58% | 54 |
|
|
2023
Q2 | $1.49M | Buy |
18,446
+13,316
| +260% | +$1.08M | 0.45% | 60 |
|
|
2023
Q1 | $408K | Buy |
+5,130
| New | +$408K | 0.14% | 114 |
|